1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Catheter-Related Bloodstream Infection (CRBSI) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Off-label Therapy 1.2.3 New Therapy 1.3 Market by Application 1.3.1 Global Catheter-Related Bloodstream Infection (CRBSI) Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Catheter-Related Bloodstream Infection (CRBSI) Market Perspective (2016-2027) 2.2 Catheter-Related Bloodstream Infection (CRBSI) Growth Trends by Regions 2.2.1 Catheter-Related Bloodstream Infection (CRBSI) Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Catheter-Related Bloodstream Infection (CRBSI) Historic Market Share by Regions (2016-2021) 2.2.3 Catheter-Related Bloodstream Infection (CRBSI) Forecasted Market Size by Regions (2022-2027) 2.3 Catheter-Related Bloodstream Infection (CRBSI) Industry Dynamic 2.3.1 Catheter-Related Bloodstream Infection (CRBSI) Market Trends 2.3.2 Catheter-Related Bloodstream Infection (CRBSI) Market Drivers 2.3.3 Catheter-Related Bloodstream Infection (CRBSI) Market Challenges 2.3.4 Catheter-Related Bloodstream Infection (CRBSI) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Catheter-Related Bloodstream Infection (CRBSI) Players by Revenue 3.1.1 Global Top Catheter-Related Bloodstream Infection (CRBSI) Players by Revenue (2016-2021) 3.1.2 Global Catheter-Related Bloodstream Infection (CRBSI) Revenue Market Share by Players (2016-2021) 3.2 Global Catheter-Related Bloodstream Infection (CRBSI) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Catheter-Related Bloodstream Infection (CRBSI) Revenue 3.4 Global Catheter-Related Bloodstream Infection (CRBSI) Market Concentration Ratio 3.4.1 Global Catheter-Related Bloodstream Infection (CRBSI) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Catheter-Related Bloodstream Infection (CRBSI) Revenue in 2020 3.5 Catheter-Related Bloodstream Infection (CRBSI) Key Players Head office and Area Served 3.6 Key Players Catheter-Related Bloodstream Infection (CRBSI) Product Solution and Service 3.7 Date of Enter into Catheter-Related Bloodstream Infection (CRBSI) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Catheter-Related Bloodstream Infection (CRBSI) Breakdown Data by Type 4.1 Global Catheter-Related Bloodstream Infection (CRBSI) Historic Market Size by Type (2016-2021) 4.2 Global Catheter-Related Bloodstream Infection (CRBSI) Forecasted Market Size by Type (2022-2027) 5 Catheter-Related Bloodstream Infection (CRBSI) Breakdown Data by Application 5.1 Global Catheter-Related Bloodstream Infection (CRBSI) Historic Market Size by Application (2016-2021) 5.2 Global Catheter-Related Bloodstream Infection (CRBSI) Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Catheter-Related Bloodstream Infection (CRBSI) Market Size (2016-2027) 6.2 North America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type 6.2.1 North America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2016-2021) 6.2.2 North America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2022-2027) 6.2.3 North America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2016-2027) 6.3 North America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application 6.3.1 North America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2016-2021) 6.3.2 North America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2022-2027) 6.3.3 North America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2016-2027) 6.4 North America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Country 6.4.1 North America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Country (2016-2021) 6.4.2 North America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Catheter-Related Bloodstream Infection (CRBSI) Market Size (2016-2027) 7.2 Europe Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type 7.2.1 Europe Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2016-2021) 7.2.2 Europe Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2022-2027) 7.2.3 Europe Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2016-2027) 7.3 Europe Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application 7.3.1 Europe Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2016-2021) 7.3.2 Europe Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2022-2027) 7.3.3 Europe Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2016-2027) 7.4 Europe Catheter-Related Bloodstream Infection (CRBSI) Market Size by Country 7.4.1 Europe Catheter-Related Bloodstream Infection (CRBSI) Market Size by Country (2016-2021) 7.4.2 Europe Catheter-Related Bloodstream Infection (CRBSI) Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Size (2016-2027) 8.2 Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type 8.2.1 Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2016-2027) 8.3 Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application 8.3.1 Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2016-2027) 8.4 Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Size by Region 8.4.1 Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Size (2016-2027) 9.2 Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type 9.2.1 Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2016-2021) 9.2.2 Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2022-2027) 9.2.3 Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2016-2027) 9.3 Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application 9.3.1 Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2016-2021) 9.3.2 Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2022-2027) 9.3.3 Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2016-2027) 9.4 Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Country 9.4.1 Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Country (2016-2021) 9.4.2 Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Size (2016-2027) 10.2 Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type 10.2.1 Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2016-2027) 10.3 Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application 10.3.1 Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2016-2027) 10.4 Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Size by Country 10.4.1 Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 CorMedix 11.1.1 CorMedix Company Details 11.1.2 CorMedix Business Overview 11.1.3 CorMedix Catheter-Related Bloodstream Infection (CRBSI) Introduction 11.1.4 CorMedix Revenue in Catheter-Related Bloodstream Infection (CRBSI) Business (2016-2021) 11.1.5 CorMedix Recent Development 11.2 Geistlich Pharma 11.2.1 Geistlich Pharma Company Details 11.2.2 Geistlich Pharma Business Overview 11.2.3 Geistlich Pharma Catheter-Related Bloodstream Infection (CRBSI) Introduction 11.2.4 Geistlich Pharma Revenue in Catheter-Related Bloodstream Infection (CRBSI) Business (2016-2021) 11.2.5 Geistlich Pharma Recent Development 11.3 TauroPharm GmbH 11.3.1 TauroPharm GmbH Company Details 11.3.2 TauroPharm GmbH Business Overview 11.3.3 TauroPharm GmbH Catheter-Related Bloodstream Infection (CRBSI) Introduction 11.3.4 TauroPharm GmbH Revenue in Catheter-Related Bloodstream Infection (CRBSI) Business (2016-2021) 11.3.5 TauroPharm GmbH Recent Development 11.4 Fresenius Medical Care 11.4.1 Fresenius Medical Care Company Details 11.4.2 Fresenius Medical Care Business Overview 11.4.3 Fresenius Medical Care Catheter-Related Bloodstream Infection (CRBSI) Introduction 11.4.4 Fresenius Medical Care Revenue in Catheter-Related Bloodstream Infection (CRBSI) Business (2016-2021) 11.4.5 Fresenius Medical Care Recent Development 11.5 Citius Pharmaceuticals 11.5.1 Citius Pharmaceuticals Company Details 11.5.2 Citius Pharmaceuticals Business Overview 11.5.3 Citius Pharmaceuticals Catheter-Related Bloodstream Infection (CRBSI) Introduction 11.5.4 Citius Pharmaceuticals Revenue in Catheter-Related Bloodstream Infection (CRBSI) Business (2016-2021) 11.5.5 Citius Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Catheter-Related Bloodstream Infection (CRBSI) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Off-label Therapy Table 3. Key Players of New Therapy Table 4. Global Catheter-Related Bloodstream Infection (CRBSI) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Catheter-Related Bloodstream Infection (CRBSI) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Catheter-Related Bloodstream Infection (CRBSI) Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Catheter-Related Bloodstream Infection (CRBSI) Market Share by Regions (2016-2021) Table 8. Global Catheter-Related Bloodstream Infection (CRBSI) Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Catheter-Related Bloodstream Infection (CRBSI) Market Share by Regions (2022-2027) Table 10. Catheter-Related Bloodstream Infection (CRBSI) Market Trends Table 11. Catheter-Related Bloodstream Infection (CRBSI) Market Drivers Table 12. Catheter-Related Bloodstream Infection (CRBSI) Market Challenges Table 13. Catheter-Related Bloodstream Infection (CRBSI) Market Restraints Table 14. Global Catheter-Related Bloodstream Infection (CRBSI) Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Catheter-Related Bloodstream Infection (CRBSI) Market Share by Players (2016-2021) Table 16. Global Top Catheter-Related Bloodstream Infection (CRBSI) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Catheter-Related Bloodstream Infection (CRBSI) as of 2020) Table 17. Ranking of Global Top Catheter-Related Bloodstream Infection (CRBSI) Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Catheter-Related Bloodstream Infection (CRBSI) Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Catheter-Related Bloodstream Infection (CRBSI) Product Solution and Service Table 21. Date of Enter into Catheter-Related Bloodstream Infection (CRBSI) Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2016-2021) (US$ Million) Table 24. Global Catheter-Related Bloodstream Infection (CRBSI) Revenue Market Share by Type (2016-2021) Table 25. Global Catheter-Related Bloodstream Infection (CRBSI) Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Catheter-Related Bloodstream Infection (CRBSI) Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Catheter-Related Bloodstream Infection (CRBSI) Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Catheter-Related Bloodstream Infection (CRBSI) Revenue Market Share by Application (2016-2021) Table 29. Global Catheter-Related Bloodstream Infection (CRBSI) Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Catheter-Related Bloodstream Infection (CRBSI) Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2016-2021) (US$ Million) Table 32. North America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2016-2021) (US$ Million) Table 34. North America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Catheter-Related Bloodstream Infection (CRBSI) Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Catheter-Related Bloodstream Infection (CRBSI) Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Size by Country (2022-2027) & (US$ Million) Table 61. CorMedix Company Details Table 62. CorMedix Business Overview Table 63. CorMedix Catheter-Related Bloodstream Infection (CRBSI) Product Table 64. CorMedix Revenue in Catheter-Related Bloodstream Infection (CRBSI) Business (2016-2021) & (US$ Million) Table 65. CorMedix Recent Development Table 66. Geistlich Pharma Company Details Table 67. Geistlich Pharma Business Overview Table 68. Geistlich Pharma Catheter-Related Bloodstream Infection (CRBSI) Product Table 69. Geistlich Pharma Revenue in Catheter-Related Bloodstream Infection (CRBSI) Business (2016-2021) & (US$ Million) Table 70. Geistlich Pharma Recent Development Table 71. TauroPharm GmbH Company Details Table 72. TauroPharm GmbH Business Overview Table 73. TauroPharm GmbH Catheter-Related Bloodstream Infection (CRBSI) Product Table 74. TauroPharm GmbH Revenue in Catheter-Related Bloodstream Infection (CRBSI) Business (2016-2021) & (US$ Million) Table 75. TauroPharm GmbH Recent Development Table 76. Fresenius Medical Care Company Details Table 77. Fresenius Medical Care Business Overview Table 78. Fresenius Medical Care Catheter-Related Bloodstream Infection (CRBSI) Product Table 79. Fresenius Medical Care Revenue in Catheter-Related Bloodstream Infection (CRBSI) Business (2016-2021) & (US$ Million) Table 80. Fresenius Medical Care Recent Development Table 81. Citius Pharmaceuticals Company Details Table 82. Citius Pharmaceuticals Business Overview Table 83. Citius Pharmaceuticals Catheter-Related Bloodstream Infection (CRBSI) Product Table 84. Citius Pharmaceuticals Revenue in Catheter-Related Bloodstream Infection (CRBSI) Business (2016-2021) & (US$ Million) Table 85. Citius Pharmaceuticals Recent Development Table 86. Research Programs/Design for This Report Table 87. Key Data Information from Secondary Sources Table 88. Key Data Information from Primary Sources List of Figures Figure 1. Global Catheter-Related Bloodstream Infection (CRBSI) Market Share by Type: 2020 VS 2027 Figure 2. Off-label Therapy Features Figure 3. New Therapy Features Figure 4. Global Catheter-Related Bloodstream Infection (CRBSI) Market Share by Application: 2020 VS 2027 Figure 5. Hospital Case Studies Figure 6. Clinic Case Studies Figure 7. Other Case Studies Figure 8. Catheter-Related Bloodstream Infection (CRBSI) Report Years Considered Figure 9. Global Catheter-Related Bloodstream Infection (CRBSI) Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Catheter-Related Bloodstream Infection (CRBSI) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Catheter-Related Bloodstream Infection (CRBSI) Market Share by Regions: 2020 VS 2027 Figure 12. Global Catheter-Related Bloodstream Infection (CRBSI) Market Share by Regions (2022-2027) Figure 13. Global Catheter-Related Bloodstream Infection (CRBSI) Market Share by Players in 2020 Figure 14. Global Top Catheter-Related Bloodstream Infection (CRBSI) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Catheter-Related Bloodstream Infection (CRBSI) as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Catheter-Related Bloodstream Infection (CRBSI) Revenue in 2020 Figure 16. Global Catheter-Related Bloodstream Infection (CRBSI) Revenue Market Share by Type (2016-2021) Figure 17. Global Catheter-Related Bloodstream Infection (CRBSI) Revenue Market Share by Type (2022-2027) Figure 18. North America Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Catheter-Related Bloodstream Infection (CRBSI) Market Share by Type (2016-2027) Figure 20. North America Catheter-Related Bloodstream Infection (CRBSI) Market Share by Application (2016-2027) Figure 21. North America Catheter-Related Bloodstream Infection (CRBSI) Market Share by Country (2016-2027) Figure 22. United States Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Catheter-Related Bloodstream Infection (CRBSI) Market Share by Type (2016-2027) Figure 26. Europe Catheter-Related Bloodstream Infection (CRBSI) Market Share by Application (2016-2027) Figure 27. Europe Catheter-Related Bloodstream Infection (CRBSI) Market Share by Country (2016-2027) Figure 28. Germany Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Share by Type (2016-2027) Figure 36. Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Share by Application (2016-2027) Figure 37. Asia-Pacific Catheter-Related Bloodstream Infection (CRBSI) Market Share by Region (2016-2027) Figure 38. China Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Share by Type (2016-2027) Figure 46. Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Share by Application (2016-2027) Figure 47. Latin America Catheter-Related Bloodstream Infection (CRBSI) Market Share by Country (2016-2027) Figure 48. Mexico Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Share by Type (2016-2027) Figure 52. Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Share by Application (2016-2027) Figure 53. Middle East & Africa Catheter-Related Bloodstream Infection (CRBSI) Market Share by Country (2016-2027) Figure 54. Turkey Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Catheter-Related Bloodstream Infection (CRBSI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. CorMedix Revenue Growth Rate in Catheter-Related Bloodstream Infection (CRBSI) Business (2016-2021) Figure 58. Geistlich Pharma Revenue Growth Rate in Catheter-Related Bloodstream Infection (CRBSI) Business (2016-2021) Figure 59. TauroPharm GmbH Revenue Growth Rate in Catheter-Related Bloodstream Infection (CRBSI) Business (2016-2021) Figure 60. Fresenius Medical Care Revenue Growth Rate in Catheter-Related Bloodstream Infection (CRBSI) Business (2016-2021) Figure 61. Citius Pharmaceuticals Revenue Growth Rate in Catheter-Related Bloodstream Infection (CRBSI) Business (2016-2021) Figure 62. Bottom-up and Top-down Approaches for This Report Figure 63. Data Triangulation Figure 64. Key Executives Interviewed

CorMedix Geistlich Pharma TauroPharm GmbH Fresenius Medical Care Citius Pharmaceuticals